Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia

Abstract

Olanzapine and risperidone appear to be prescribed to patients with different sociodemographic and clinical characteristics. Future research needs to explore the reasons for those differences.

Patterns of clozapine prescribing in a mental health service in New Zealand

“…Again, as one would expect from the literature [27,28], many patients also had physical health co-morbidity. The most common of these were gastrointestinal (22.1%), endocrine (14.7%), respiratory (10.7%) and cardiac (9.7%) disorders.…”

Antipsychotic Prescribing Pathways, Polypharmacy, and Clozapine Use in Treatment of Schizophrenia

“…Because the VHA has used electronic records for clinical care for many years, readily available administrative data sets can be used to identify and describe longitudinal antipsychotic prescribing pathways. Administrative data have been used extensively in other antipsychotic studies (11,20,(26)(27)(28). …”

The Relationship of Antipsychotic Medication Class and Adherence with Treatment Outcomes and Costs for Florida Medicaid Beneficiaries with Schizophrenia

“…Fourth, there are apparent systematic biases in the decision to place recipients on AA or TA medications. People who are white, have a substance abuse diagnosis or have a mood disorder are more likely to be placed on AA medications (Daumit et al, 2003;Herbeck et al, 2004;Ren et al, 2002). Fifth, our outcome measures were limited.…”